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Neisseria meningitidis (Nm) is a commensal gram-negative bacterium that colonizes the upper 
respiratory nasopharynx and only in rare cases causes life-threatening invasive meningococcal 
disease (IMD). Genetic analysis of whole exome sequencing undertaken in familial IMD cases 
revealed a novel missense mutation in BPIFA1 gene. The encoding protein is specifically expressed in 
the human nasopharyngeal mucosa as part of the host innate immune defence against infectious 
agents in the airway. Previous studies have shown that BPIFA1 has a role in host defence against 
other Gram-negative bacteria and viruses, possibly through inhibition of biofilm formation or import 
of viral particles into epithelial cells.  The objective of this study was to characterise the role of 
BPIFA1 in the context of meningococcal infection and investigate whether the novel missense 
mutation leads to increased susceptibility to IMD in the carriers. 
Method: 
We tested the recombinant BPIFA1 activity on Nm biofilm formation as well as bacterial adhesion 
and invasion of airway epithelial cells. We used transfection in cultured cells, with recombinant 
expression plasmids encoding WT or mutant BPIFA1 to assess the functional effect at protein and 
mRNA levels.  
Results: 
We showed that recombinant BPIFA1 significantly inhibits Nm biofilm formation. Using in-vitro 
human colonisation models, we demonstrated that purified BPIFA1 is protective against Nm 
infection by deterring bacterial adherence and invasion of the epithelial cells. In addition, the mutant 
protein had impaired ability in anti-biofilm and adhesion and invasion defences of the epithelial 
cells.  
Conclusion: 
Our results demonstrated that BPIFA1 plays an important host immune defence role against Nm 
infection. The identified missense mutation may have the potential to predispose carriers to invasive 
pathogenic infections such as IMD.  
